CLA Soft Chew
Natural health product licensed in Canada
- Licence holder
- GNC Canada Holdings ULC
- NPN or DIN-HM
- 80047236
- Status
- Inactive licence
- Licence date
- 16 December 2013
- Revision date
- Not provided
- Form
- Bloc
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide linoléique conjugué Source : Acide linoléique conjugué | 500 mg | Not calculated |
Non-medicinal ingredients
jus de fruits, Gomme arabique (acacia), Sirop de maltitol, Acide DL-malique, Glycérine, Sucralose, Base colorante de l'huile de tournesol(Huile de tournesol, maltodextrine, caséinate de sodium, mono & diglycérides, phosphate dipotassique, lécithine de soja, silicoaluminate de sodium et tocophérols), Carraghénine, Isolat de protéine de soja, Lécithine, Jus de légumes, Sirop de maïs solide, Maltodextrine, Saveur, Poly(dextrose)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Bloc(s) | 3 days |
Uses authorised in Canada
May help to support a modest improvement to body composition when used with a program of reduced intake of dietary calories and increased physical activity. May help to support a modest reduction in fat mass when used with a program of reduced intake of dietary calories and increased physical activity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have CVD, diabetes, metabolic syndrome or insulin resistance.
- Effets indésirables connus
Some people may experience gastrointestinal upset.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are obese or have cardiovascular disease (CVD) risk factors (e.g. high blood pressure, high cholesterol and/or triglycerides). Consult a health care practitioner prior to use if you are pregnant or breastfeeding . Consult a health care practitioner prior to use if your goal is to achieve weight loss.
Source
Official Health Canada record, licence 80047236
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.